Nanoparticles & Advanced Drug Delivery Systems

Personalized medicine means to individualize chemotherapeutic intercessions on the basis of ex vivo and in vivo data on patient-and disease-specific characteristics. The origin of personalized medicine resulted in the birth of different fields such as pharmacogenomics,proteomics, and metabolomics in the early 2000’s. This enabled the genetic study of every individual. It mainly aims at the development of patient specific treatment considering the genotype, phenotype and environmental factors that can influence the efficacy and safety of the therapy. This has experienced an exponential increase as it created an opportunity to treat every individual or a group of individuals who share common characteristics by taking the specific changes that have occurred at their genomic level. Even if the availability of nanomedicine products is high, not even a single one is designed as a personalized medicine because of the decreased number of publications concerning the personalized medicine.